Thursday, 24 July 2025

Jamjoom Pharma Q2 Profits Rise 23.4% to SAR 132 Mln

Jamjoom Pharmaceuticals Factory Co. reported on Thursday a net profit of SAR 132 million in the second quarter of 2025, compared to SAR 107 million in the same quarter last year, a 23.4% increase. This came after the announcement today of the estimated financial results for the (six-month) period ending June 30, 2025.

Operational profit reached SAR 135.3 million in the second quarter of 2025, compared to SAR 105 million in the same quarter of the previous year, a 29% increase.

 Profits per share reached SAR 4.13 in the second quarter, compared to SAR 3 in the same quarter of the previous year.

اقرأ المزيد

 

According to the Company, net profit increased by 23.4% during the current quarter compared to the same quarter last year, driven primarily by improved operational efficiency, disciplined cost management, and improved profit margins across the business.

Related





Articles